Evidence map›Paper›PMID 38923862›Full record

ArticleNeuropsychopharmacology reports2024

Major depressive disorder after heart transplantation with partial response to antidepressant therapy and remission with aripiprazole augmentation: A case report.

Toshinori Nakamura, Yuta Kuraishi, Dai Ohya, Kazuhiro Kimura, Daimei Sasayama, Shinsuke Washizuka

Abstract readCase Reports
In one paragraph

Article in Neuropsychopharmacology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Toshinori NakamuraDepartment of Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.ORCID 0000-0001-8129-4220
Yuta KuraishiDepartment of Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Dai OhyaDepartment of Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Kazuhiro KimuraDepartment of Cardiovascular Medicine, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Daimei SasayamaDepartment of Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.ORCID 0000-0003-3450-7283
Shinsuke WashizukaDepartment of Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of major depressive disorder (MDD) after heart transplantation is high; however, there are no reports on treatment options when antidepressant therapy fails to improve the condition. We herein report on the case of a woman with MDD after heart transplantation who partially improved with antidepressant treatment but continued to have a loss of appetite. Augmentation treatment with aripiprazole improved her appetite, and her MDD went into remission. When antidepressant treatment is not sufficiently effective for MDD after heart transplantation, augmentation treatment with antipsychotics, such as aripiprazole, should be considered.

Indexed as

Antidepressive AgentsAripiprazoleHeart TransplantationMajor Depressive DisorderAntipsychotic AgentsDrug Therapy, CombinationFemaleHumansMiddle AgedRemission InductionAntidepressive AgentsAntipsychotic AgentsAripiprazoleantidepressantantipsychoticsaripiprazoledepressionheart transplant

Identifiers

PMID38923862
PMCPMC11544448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.